News Understanding Sysmex

Select your local Sysmex website

JAPAN

AMERICAS

EMEA

ASIA PACIFIC

GLOBAL HEADQUARTERS (JAPAN)

REGIONAL HEADQUARTERS

OTHER SYSMEX GROUP COMPANIES

Together for a better
healthcare journey

    Story

    Ensuring that Medical Services and Testing Never Stop: Technical Services Supporting Frontline Healthcare Workers

    Bringing New Options for Cancer Treatment: Market Development for Cancer Gene Panel Testing

    Delivering High-Quality Made in Japan Products to the World: Production Transfer Project to India
    See more Stories
    News
    1. Press Release
      Sysmex and the United Graduate School of Child Development, the University of Osaka to Establish a Joint Research Department to Elucidate Pathology and Develop New Diagnostic Techniques for Neurodevelopmental and Neurodegenerative Diseases
    2. Information
      Sysmex’s Automated Blood Coagulation Analyzer CN™-6000 Receives U.S. FDA 510(k) Clearance
    3. Press Release
      Sysmex Completes Subsidiary's New Instrument Manufacturing Factory in Nagano, Japan, and Begins Product Shipments
      - Strengthening the Group’s Instrument Production System to Ensure Stable Global Supply and Enhanced Productivity -
    4. Press Release
      Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (PDF：357KB)
    5. Press Release
      Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2025 (PDF：130KB)
    6. Press Release
      Notification Regarding Reversal of Deferred Tax Assets (Non-Consolidated Financial Results) (PDF：97KB)
    7. Press Release
      Announcement of Executive Changes (PDF：205KB)
    8. Press Release
      Announcement Regarding the Introduction of the Performance-Linked Stock Compensation Plan (PDF：216KB)
    Go to News
    Topics
    1. Released "Ensuring that Medical Services and Testing Never Stop: Technical Services Supporting Frontline Healthcare Workers" on Our Stories
    2. Released "Bringing New Options for Cancer Treatment: Market Development for Cancer Gene Panel Testing" on Our Stories
    3. Business Results Announcement for the Fiscal Year Ended March 31, 2025 (See Latest Financial Statements)
    Go to Topics

    Discover Sysmex

    Company Information

    Business Introduction

    Sustainability

    Movie

    Brand Concept Moive
    Corporate Introduction Movie
    Sysmex Official YouTube Channel

    About Testings and Diseases

    The Basics of Hematology

    Sysmex’s Approach to Dementia

    Sysmex’s Initiatives Against Antimicrobial Resistance (AMR)